PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis

The combination of programmed cell death-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitors with chemotherapy has emerged as a promising therapeutic option for advanced non-small-cell lung cancer (NSCLC). The aim of this meta-analysis was to evaluate the efficacy of the combined strategy in this...

Descripción completa

Detalles Bibliográficos
Autores principales: García-González, Jorge, Ruiz-Bañobre, Juan, Afonso-Afonso, Francisco J., Amenedo-Gancedo, Margarita, Areses-Manrique, María del Carmen, Campos-Balea, Begoña, Casal-Rubio, Joaquín, Fernández-Núñez, Natalia, Fírvida Pérez, José Luis, Lázaro-Quintela, Martín, Pérez Parente, Diego, Crama, Leonardo, Ruiz-Gracia, Pedro, Santomé-Couto, Lucía, León-Mateos, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408884/
https://www.ncbi.nlm.nih.gov/pubmed/32635291
http://dx.doi.org/10.3390/jcm9072093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408884/
https://www.ncbi.nlm.nih.gov/pubmed/32635291
http://dx.doi.org/10.3390/jcm9072093

Ejemplares similares